TY -的T1为血管内开发实践建议重建术对急性缺血性中风JF -神经学乔-神经病学SP - S243 LP - S255做- 10.1212 / WNL。首页0 b013e31826959fc六世- 79 - 13补充1 AU -马克·a·非盟一员-罗伯塔·l·Novakovic AU -安德烈诉Alexandrov盟济Darkhabani AU -兰德尔·c·Edgell AU -乔伊英语非盟-唐纳德·弗雷AU -达拉g . Jamieson盟Vallabh Janardhan AU -萨他非盟-拉希德m .他盟艾琳Katzan盟Pooja Khatri AU - Jawad f•基尔马尼盟David s . Liebeskind AU - Italo Linfante盟Thanh n阮AU - Jeffrey l .节省盟Lori快门AU -安德鲁·泽维尔盟Dileep Yavagal AU -奥萨马o . Zaidat Y1 - 2012/09/25 UR - //www.ez-admanager.com/content/79/13_Supplement_1/S243.abstract N2 -管理准则建立了急性缺血性中风;首页然而,缺乏血管内血管再生疗法的具体建议。蓬勃发展的调查血管内血管再生治疗急性缺血性中风,设备迅速发展,多样化的培训提供者执行程序的背景强调需要实践的建议。本文提供了一个简明的血管和神经学介入社会的血管内急性缺血性中风圆桌会议。首页本文档是审查当前的临床疗效的药物开发和机械血管再生疗法,选择标准,periprocedure管理和血管内时间指标和突出当前的实践模式。因此为未来的发展提供了一个轮廓multisociety指导方针和建议,改善病人的选择、过程管理和组织血管再生疗法在急性缺血性中风的策略。行动=激活凝血时间;啊哈=美国心脏协会;AIS =急性缺血性中风; ASA =American Stroke Association; ASPECTS =Alberta Stroke Program Early CT score; CI =confidence interval; ECASS =European Cooperative Acute Stroke Study III; ED =emergency department; EMS =emergency medical services; ERT =endovascular revascularization therapy; FDA =US Food and Drug Administration; IA =intra-arterial; ICH =intracranial hemorrhage; IMS =Interventional Management of Stroke; J-MUSIC =Japan Multicenter Stroke Investigators'Collaboration; MCA =middle cerebral artery; MELT =MCA-Embolism Local fibrinolytic intervention Trial; MERCI =Mechanical Embolus Removal in Cerebral Ischemia; MR CLEAN =Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands; MR RESCUE =MR and Recanalization of Stroke Clots Using Embolectomy; mRS =modified Rankin Scale; NIHSS =NIH Stroke Scale; NINDS =National Institute of Neurological Disorders and Stroke; OR =odds ratio; PROACT =Prolyse in Acute Cerebral Thromboembolism; rtPA =recombinant tissue plasminogen activator; sICH =symptomatic ICH; SYNTHESIS EXP=Intra-Arterial Versus Systemic Thrombolysis for Acute Ischemic Stroke; THERAPY =Assess the Penumbra System in the Treatment of Acute Stroke; VBO =vertebrobasilar occlusion ER -